Pfizer Inc. - stock earnings
PFE Upcoming estimated earnings
Date | Low Revenue | Average Revenue | High Revenue |
---|---|---|---|
April 30, 2024 BeforeMarket | 12.8 billion | 14.2 billion | 16.5 billion |
PFE Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -3.3 billion USD | 14.2 billion USD |
2023Q3 | -2.4 billion USD | 13.2 billion USD |
2023Q2 | 2.3 billion USD | 12.7 billion USD |
2023Q1 | 5.5 billion USD | 18.3 billion USD |
2022Q4 | 5.0 billion USD | 24.3 billion USD |
2022Q3 | 8.6 billion USD | 22.6 billion USD |
2022Q2 | 9.9 billion USD | 27.7 billion USD |
2022Q1 | 7.9 billion USD | 25.7 billion USD |
2021Q4 | 3.4 billion USD | 23.8 billion USD |
2021Q3 | 8.1 billion USD | 24.1 billion USD |
2021Q2 | 5.6 billion USD | 19.0 billion USD |
2021Q1 | 4.9 billion USD | 14.6 billion USD |
2020Q4 | 594.0 million USD | 11.7 billion USD |
2020Q3 | 2.2 billion USD | 12.1 billion USD |
2020Q2 | 3.4 billion USD | 11.8 billion USD |
2020Q1 | 3.4 billion USD | 12.0 billion USD |
2019Q4 | -337.0 million USD | 12.7 billion USD |
2019Q3 | 7.7 billion USD | 12.7 billion USD |
2019Q2 | 5.0 billion USD | 13.3 billion USD |
2019Q1 | 3.9 billion USD | 13.1 billion USD |
2018Q4 | -394.0 million USD | 14.0 billion USD |
2018Q3 | 4.1 billion USD | 13.3 billion USD |
2018Q2 | 3.9 billion USD | 13.5 billion USD |
2018Q1 | 3.6 billion USD | 12.9 billion USD |
2017Q4 | 12.3 billion USD | 13.7 billion USD |
2017Q3 | 2.8 billion USD | 13.2 billion USD |
2017Q2 | 3.1 billion USD | 12.9 billion USD |
2017Q1 | 3.1 billion USD | 12.8 billion USD |
2016Q4 | 775.0 million USD | 13.6 billion USD |
2016Q3 | 1.3 billion USD | 13.0 billion USD |
2016Q2 | 2.0 billion USD | 13.1 billion USD |
2016Q1 | 3.0 billion USD | 13.0 billion USD |
2015Q4 | -172.0 million USD | 14.0 billion USD |
2015Q3 | 2.1 billion USD | 12.1 billion USD |
2015Q2 | 2.6 billion USD | 11.9 billion USD |
2015Q1 | 2.4 billion USD | 10.9 billion USD |
2014Q4 | 1.2 billion USD | 13.1 billion USD |
2014Q3 | 2.7 billion USD | 12.4 billion USD |
2014Q2 | 2.9 billion USD | 12.8 billion USD |
2014Q1 | 2.3 billion USD | 11.4 billion USD |
2013Q4 | 2.6 billion USD | 13.6 billion USD |
2013Q3 | 2.6 billion USD | 12.6 billion USD |
2013Q2 | 14.1 billion USD | 13.0 billion USD |
2013Q1 | 2.8 billion USD | 13.5 billion USD |
2012Q4 | 6.3 billion USD | 15.1 billion USD |
2012Q3 | 3.2 billion USD | 14.0 billion USD |
2012Q2 | 3.3 billion USD | 15.1 billion USD |
2012Q1 | 1.8 billion USD | 15.4 billion USD |
2011Q4 | 1.4 billion USD | 16.7 billion USD |
2011Q3 | 3.7 billion USD | 17.2 billion USD |
2011Q2 | 2.6 billion USD | 17.0 billion USD |
2011Q1 | 2.2 billion USD | 16.5 billion USD |
2010Q4 | 2.9 billion USD | 17.6 billion USD |
2010Q3 | 866.0 million USD | 16.2 billion USD |
2010Q2 | 2.5 billion USD | 17.3 billion USD |
2010Q1 | 2.0 billion USD | 16.8 billion USD |
2009Q4 | 767.0 million USD | 16.5 billion USD |
2009Q3 | 2.9 billion USD | 11.6 billion USD |
2009Q2 | 2.3 billion USD | 11.0 billion USD |
2009Q1 | 2.7 billion USD | 10.9 billion USD |
2008Q4 | 266.0 million USD | 12.3 billion USD |
2008Q3 | 2.3 billion USD | 12.0 billion USD |
2008Q2 | 2.8 billion USD | 12.1 billion USD |
2008Q1 | 2.8 billion USD | 11.8 billion USD |
2007Q4 | 2.7 billion USD | 12.9 billion USD |
2007Q3 | 761.0 million USD | 12.0 billion USD |
2007Q2 | 1.3 billion USD | 11.1 billion USD |
2007Q1 | 3.4 billion USD | 12.5 billion USD |
2006Q4 | 9.4 billion USD | 12.6 billion USD |
2006Q3 | 3.4 billion USD | 12.3 billion USD |
2006Q2 | 2.4 billion USD | 11.7 billion USD |
2006Q1 | 4.1 billion USD | 12.7 billion USD |
2005Q4 | 2.7 billion USD | 13.6 billion USD |
2005Q3 | 1.6 billion USD | 12.2 billion USD |
2005Q2 | 3.5 billion USD | 12.4 billion USD |
2005Q1 | 301.0 million USD | 13.1 billion USD |
2004Q4 | 2.8 billion USD | 14.9 billion USD |
2004Q3 | 3.3 billion USD | 12.8 billion USD |
2004Q2 | 2.9 billion USD | 12.3 billion USD |
2004Q1 | 2.3 billion USD | 12.5 billion USD |
2003Q4 | 602.0 million USD | 14.2 billion USD |
2003Q3 | 2.2 billion USD | 12.5 billion USD |
2003Q2 | -3.6 billion USD | 10.0 billion USD |
2003Q1 | 4.7 billion USD | 8.5 billion USD |
2002Q4 | 2.9 billion USD | 7.2 billion USD |
2002Q3 | 2.4 billion USD | 8.7 billion USD |
2002Q2 | 2.0 billion USD | 8.0 billion USD |
2002Q1 | 2.4 billion USD | 8.4 billion USD |
2001Q4 | 2.0 billion USD | 9.0 billion USD |
2001Q3 | 2.1 billion USD | 7.9 billion USD |
2001Q2 | 1.8 billion USD | 7.7 billion USD |
2001Q1 | 1.9 billion USD | 7.6 billion USD |
2000Q4 | 1.4 billion USD | 8.1 billion USD |
2000Q3 | 1.4 billion USD | 7.2 billion USD |
2000Q2 | 1.2 billion USD | 7.0 billion USD |
2000Q1 | 1.2 billion USD | 4.3 billion USD |
1999Q4 | 954.0 million USD | 4.5 billion USD |
1999Q3 | 701.0 million USD | 4.0 billion USD |
1999Q2 | 709.0 million USD | 3.8 billion USD |
1999Q1 | 815.0 million USD | 3.9 billion USD |
1998Q4 | 634.0 million USD | 3.9 billion USD |
1998Q3 | 1.4 billion USD | 3.3 billion USD |
1998Q2 | 628.0 million USD | 3.6 billion USD |
1998Q1 | 692.0 million USD | 3.3 billion USD |
1997Q4 | 558.0 million USD | 3.5 billion USD |
1997Q3 | 596.0 million USD | 3.1 billion USD |
1997Q2 | 457.0 million USD | 2.9 billion USD |
1997Q1 | 602.0 million USD | 3.0 billion USD |
1996Q4 | 504.0 million USD | 3.2 billion USD |
1996Q3 | 514.0 million USD | 2.8 billion USD |
1996Q2 | 394.0 million USD | 2.7 billion USD |
1996Q1 | 517.0 million USD | 2.7 billion USD |
1995Q4 | 410.9 million USD | 2.7 billion USD |
1995Q3 | 425.3 million USD | 2.5 billion USD |
1995Q2 | 316.3 million USD | 2.5 billion USD |
1995Q1 | 420.4 million USD | 2.4 billion USD |
1994Q4 | 334.0 million USD | 2.3 billion USD |
1994Q3 | 336.5 million USD | 2.1 billion USD |
1994Q2 | 257.2 million USD | 1.9 billion USD |
1994Q1 | 370.7 million USD | 2.0 billion USD |
1993Q4 | 288.9 million USD | 2.0 billion USD |
1993Q3 | -214.2 million USD | 1.9 billion USD |
1993Q2 | 253.8 million USD | 1.7 billion USD |
1993Q1 | 329.0 million USD | 1.9 billion USD |
1992Q4 | 14.5 million USD | 1.9 billion USD |
1992Q3 | 297.5 million USD | 1.8 billion USD |
1992Q2 | 203.8 million USD | 1.7 billion USD |
1992Q1 | 295.1 million USD | 1.8 billion USD |
1991Q4 | 900000 USD | 1.9 billion USD |
1991Q3 | 274.7 million USD | 1.8 billion USD |
1991Q2 | 179.1 million USD | 1.6 billion USD |
1991Q1 | 267.4 million USD | 1.7 billion USD |
1990Q4 | 154.8 million USD | 1.8 billion USD |
1990Q3 | 243.3 million USD | 1.6 billion USD |
1990Q2 | 151.2 million USD | 1.5 billion USD |
1990Q1 | 251.9 million USD | 1.5 billion USD |
1989Q4 | ? USD | 1.5 billion USD |
1989Q3 | ? USD | 1.4 billion USD |
1989Q2 | ? USD | 1.3 billion USD |
1989Q1 | ? USD | 1.4 billion USD |
1988Q4 | ? USD | 1.4 billion USD |
1988Q3 | ? USD | 1.4 billion USD |
1988Q2 | ? USD | 1.3 billion USD |
1988Q1 | ? USD | 1.3 billion USD |
1987Q4 | ? USD | 1.3 billion USD |
1987Q3 | ? USD | 1.3 billion USD |
1987Q2 | ? USD | 1.2 billion USD |
1987Q1 | ? USD | 1.1 billion USD |
1986Q4 | ? USD | 1.2 billion USD |
1986Q3 | ? USD | 1.2 billion USD |
1986Q2 | ? USD | 1.1 billion USD |
1986Q1 | ? USD | 1.0 billion USD |
1985Q4 | ? USD | 1.1 billion USD |
1985Q3 | ? USD | 1.0 billion USD |
PFE Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 2.1 billion USD | 58.5 billion USD |
2022 | 31.4 billion USD | 100.3 billion USD |
2021 | 22.0 billion USD | 81.3 billion USD |
2020 | 7.0 billion USD | 41.9 billion USD |
2019 | 16.3 billion USD | 51.8 billion USD |
2018 | 11.2 billion USD | 53.6 billion USD |
2017 | 21.3 billion USD | 52.5 billion USD |
2016 | 7.2 billion USD | 52.8 billion USD |
2015 | 7.0 billion USD | 48.9 billion USD |
2014 | 9.1 billion USD | 49.6 billion USD |
2013 | 22.0 billion USD | 51.6 billion USD |
2012 | 14.6 billion USD | 59.0 billion USD |
2011 | 10.0 billion USD | 67.4 billion USD |
2010 | 8.3 billion USD | 67.8 billion USD |
2009 | 8.6 billion USD | 50.0 billion USD |
2008 | 8.1 billion USD | 48.3 billion USD |
2007 | 8.1 billion USD | 48.4 billion USD |
2006 | 19.3 billion USD | 48.4 billion USD |
2005 | 8.1 billion USD | 51.3 billion USD |
2004 | 11.4 billion USD | 52.5 billion USD |
2003 | 3.9 billion USD | 45.2 billion USD |
2002 | 9.1 billion USD | 32.4 billion USD |
2001 | 7.8 billion USD | 32.3 billion USD |
2000 | 3.7 billion USD | 29.6 billion USD |
1999 | 3.2 billion USD | 16.2 billion USD |
1998 | 3.4 billion USD | 13.5 billion USD |
1997 | 2.2 billion USD | 12.5 billion USD |
1996 | 1.9 billion USD | 11.3 billion USD |
1995 | 1.6 billion USD | 10.0 billion USD |
1994 | 1.3 billion USD | 8.3 billion USD |
1993 | 657.5 million USD | 7.5 billion USD |
1992 | 810.9 million USD | 7.2 billion USD |
1991 | 722.1 million USD | 7.0 billion USD |
1990 | 801.2 million USD | 6.4 billion USD |
1989 | 681.1 million USD | 5.7 billion USD |
1988 | 791.3 million USD | 5.4 billion USD |
1987 | 690.2 million USD | 4.9 billion USD |
1986 | 660.0 million USD | 4.5 billion USD |
1985 | 579.7 million USD | 4.0 billion USD |
PFE
List: Contenders
Price: 27.75USD
Dividend Yield: 6.07%
Forward Dividend Yield: 6.05%
Payout Ratio: 454.05%
Dividend Per Share: 1.68 USD
Earnings Per Share: 0.37 USD
P/E Ratio: 72.78
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 23.8 million
Ebitda: 3.6 billionMarket Capitalization: 156.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 53
DGR3: 5.15%
DGR5: 6.95%
DGR10: 6.50%
DGR20: 8.23%